Bioxcel therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Bioxcel therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 9.134 million compared to usd 5.119 million a year ago. net loss was usd 9.018 million compared to usd 4.887 million a year ago. basic loss per share was usd 0.57 compared to usd 0.31 a year ago. for the nine months, operating loss was usd 25.188 million compared to usd 12.649 million a year ago. net loss was usd 24.693 million compared to usd 12.195 million a year ago. basic loss per share was usd 1.57 compared to usd 0.86 a year ago.
BTAI Ratings Summary
BTAI Quant Ranking